Forecast Pharma Revenue Without the Cliff Myth
The Cliff Myth in Pharma Revenue Forecasting: Why Relying on It Could Be Costing You Millions
In the high-stakes world of pharmaceutical innovation and investment, the narrative of the “patent cliff” has long served as a cautionary tale—and a forecasti…
